Acumen Research and Consulting Ophthalmic Drugs Market

The global Ophthalmic Drugs Market size is estimated to grow at CAGR above 4.2% over the forecast time frame 2019-2026 and reach the market value around USD 40 billion by 2026. The growth of the ophthalmic therapeutic market is driven by increased funding from public and private bodies to research on ocular disorders, with the presence of strongly emerging pipeline drugs. Shire and Parion Sciences, for example, collaborated to develop and marketP-321, which is used in adult dry- eye diseases. Furthermore, approval for new products is expected to promote the market for the treatment of eye disorders. Would like to place an order or any question, please feel free to contact at [email protected] | [phone]